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Consistent with an essential role for BER in repair of endogenous damage in mammals, embryonic lethality in mice is caused by disruptions of the genes encoding several of the proteins required for steps in BER, including AP endonuclease, DNA pol β, and the XRCC1 protein that, as a complex with Ligase III, is important for rejoining of strand breaks ( Fig. 1 ; reviewed by Wilson and Thompson 1997) . There is a significantly milder phenotype for knockouts of particular glycosylases, e.g. AAG (Engelward et al. 1997) , OGG1 (Klungland et al. 1999b; Minowa et al. 2000) , and UNG (Nilsen et al. 2000) . These observations could imply either a relative lack of toxicity of their respective substrates or, perhaps more likely, the presence of backup repair enzymes or processes not readily detected by assaying cell extracts.
Transcription-Coupled DNA Repair: Multiple Excision Pathways
Strand-specific repair of transcribed strands of active genes was initially discovered for repair of UV damage in mammalian cells. Such transcription-coupled NER (TC-NER) has been shown to occur in E. coli (Mellon and Hanawalt 1989) , S. cerevisiae (Leadon and Lawrence 1992; Smerdon and Thoma 1990; Sweder and Hanawalt 1992) , and rodent and human cells (Leadon and Lawrence 1991; Mellon et al. 1987) . XPC is the only protein required for global NER that is not also required for TC-NER (Evans et al. 1993b; Nouspikel et al. 1997; Venema et al. 1991; Venema et al. 1990 ). This finding has two implications. First, lesion removal in TCR of UV and other bulky lesions is apparently performed by NER enzymes. This conclusion agrees with the finding that the patch size of 30 nt for TC-NER is similar to the patch size of global NER (Bowman et al. 1997) . Second, since XPC is required for recognition of the lesion in global NER (Sugasawa et al. 1998) , identification of the lesion must occur by another means in TC-NER. Active on-going transcription by RNA pol II is required for TCR (Leadon and Lawrence 1991; Leadon and Lawrence 1992; Sweder and Hanawalt 1992) , and it is postulated that it is stalling of RNAP II at a lesion that serves as the signal for initiating preferential repair by TC-NER. Transcription by RNA pol I and pol III apparently does not lead to TC-NER (Christians and Hanawalt 1993; Dammann and Pfeifer 1997; Vos and Wauthier 1991) .
Transcription-Coupled Repair is a Process Distinct from NER. One of the first indications that TCR might also direct BER in addition to NER was the finding of more rapid repair of lesions produced by ionizing radiation (IR) in the TS compared to the NTS of an active gene in normal human cells, as 5 shown by a method that follows the insertion of repair patches ( Fig. 2A ; Leadon and Cooper 1993) .
Much of the DNA damage induced by IR results indirectly from attack by reactive oxygen species (ROS) produced by ionization of water molecules and hence resembles endogenous damage to DNA from ROS produced by the cellular metabolism. While a large variety of base damages and strand breaks with non-ligatable blocked 3'-ends result from ROS attack on DNA, most of these are repaired by BER. Direct examination of removal of a particular prominent, stable oxidatively damaged base, thymine glycol (Tg), by use of a monoclonal antibody against the lesion revealed that these lesions were repaired much faster in the TS than the NTS in both the yeast S. cerevisiae (Leadon and Lawrence 1992) and normal human cells ( Fig. 2B ; Cooper et al. 1997 ) after treatment with hydrogen peroxide. Tg is a lethal lesion that has been shown to block both prokaryotic DNA and RNA polymerases in vitro (Evans et al. 1993a; Hatahet et al. 1994) , and its removal in human cells is initiated by an evolutionarily conserved glycosylase/AP lyase activity closely related to E. coli endonuclease III, or NTH (Aspinwall et al. 1997) . Indeed, the observed TCR of IR damage in general (Leadon and Cooper 1993) and of Tg in particular Le Page et al. 2000b ; Leadon et al. 1995) was found not to depend on NER. Thus, TCR of oxidative damage occurs at the same rapid rate in TS of normal human cells or those having either defective XPA or XPF, defects in the incision function of XPG, or defects in the NER function of XPD ( Fig. 2A,B ).
An oxidatively damaged form of guanine, 7, or GO) , is an important pre-mutagenic lesion due to its potential to mispair with A, thus generating GC to TA transversions, and its biological significance is underscored by the existence of an evolutionarily conserved three-tiered "GO system" to prevent its presence in the genome (reviewed in Boiteux and Radicella 1999) . Its removal in human cells is initiated primarily by OGG1, a glycosylase/AP lyase that is functionally equivalent to the E. coli Fpg (MutM) protein (Radicella et al. 1997; Roldán-Arjona et al. 1997; Rosenquist et al. 1997) . That this particular damaged base is also repaired by TCR was demonstrated using an SV40-based shuttle vector containing a single 8-oxoG in the 3'-UTR of the T antigen (TAg) gene. Transcription of the sequence containing the lesion was determined by presence or absence of the SV40 early promoter in the vector, which was transfected into various human cell strains and recovered after incubation for analysis of persistence of the lesion (Le Page et al. 2000b) . The site-6 specifically placed 8-oxoG was removed faster when in a transcribed sequence than when not transcribed in both normal human cells and cells defective in NER (Fig. 2C) , providing further support for the concept of transcription-coupled BER (TC-BER). While this NER-independent transcriptioncoupled pathway has thus now been demonstrated for both Tg and 8-oxoG, it is evident from the extent of repair synthesis in transcribed strands in human cells after IR ( Fig. 2A ) that other oxidative lesions must also be subject to TC-BER, but their identities are not yet known.
The Link Between Transcription-Coupled Repair and Human Genetic Disease
Cockayne Syndrome. XP patients have inherited mutations affecting genes required for NER and are extremely sensitive to sunlight, have pronounced skin changes in sun-exposed areas, and are highly prone to skin cancer due to inability to carry out either global or transcription-coupled repair of UV-induced lesions in DNA. A distinctly different sun-sensitive hereditary disease, Cockayne syndrome (CS), is characterized by small size at birth followed by postnatal developmental failure involving a complex clinical picture that includes wasting, profound retardation, progressive and severe neurological deterioration during infancy and early childhood, and early death (Nance and Berry 1992) .
Unlike XP, the sensitivity of the skin to sunlight does not lead to a predisposition to skin cancer. CS most often arises from mutations in the CSA or CSB genes. Involvement of these genes in TCR (and in fact the first hint of the existence of a repair pathway preferential for transcribed DNA) was implied by the observation that, while cells from normal individuals recover from the inhibition of RNA synthesis that occurs after UV irradiation, CS-A or CS-B cells do not (Mayne and Lehmann 1982) although their global NER is normal. Both types of mutant cells were later shown to be defective in TC-NER (Leadon and Cooper 1993; van Hoffen et al. 1993) , and it is now clear that both CSA and CSB proteins are essential for this process. However, early observations with CS cells showed them to be unusual in displaying cross-sensitivity to both UV and IR (Chan and Little 1981; Deschavanne et al. 1984; Deschavanne et al. 1981) , and indeed TCR of IR-induced damage and of both Tg and 8-oxoG removal was found also to depend on CSB ( Fig. 2 ; Cooper et al. 1997; Le Page et al. 2000b; Leadon and Cooper 1993) . In contrast, although CSA is stringently required for TC-NER, CS-A cells are able to preferentially repair oxidative damage in TS, albeit at a reduced rate relative to cells from normal 7 individuals ( Fig. 2A ; Leadon and Cooper 1993) . Apparently both CSA and CSB play indispensable roles in TC-NER but only the latter is strictly required for TC-BER (Table 1) .
Cockayne Syndrome combined with Xeroderma Pigmentosum. In rare cases, CS is due to mutations in either the XPB, XPD, or XPG genes that encode proteins essential for NER and that usually result in XP when defective ( Fig. 1; Table 1 ). Because XP-A patients completely lacking NER do not exhibit clinical features of CS, the involvement of these three genes in CS is a priori unlikely to be due to their roles in NER. For XP-G patients, there is a striking correlation between the nature of the mutation and the clinical symptoms. Mutations that confer severe infantile CS (class 3) are those that lead to extreme truncation of the protein, whereas conservative single amino acid substitutions or other changes that severely reduce or eliminate XPG enzymatic activity but allow the production of full-length protein result in XP only (class 1) or XP with limited or late onset CS-like symptoms (class 2) ( ) and unpublished data). Since class I XPG mutations eliminate NER by severely reducing the enzymatic activity of XPG but do not lead to CS symptoms, the endonucleolytic function of XPG must not be related to CS . Similarly, most mutations in XPD that inactivate its helicase function, which is essential for unwinding around the lesion in NER, result in XP but not CS.
Since both XPB and XPD are essential for transcription initiation as part of TFIIH, only conservative mutations in these genes are consistent with viability, and probably for this reason analysis of the XPD mutations in the very few XP-D/CS patients has not been particularly informative thus far (Thompson 1998) . Nonetheless, for the set of distinct mutations in either XPD or XPG, the striking difference in severity of the clinical phenotype of XP vs. XP/CS is consistent with alterations in different functions of the encoded protein. An obvious potential candidate for the relevant non-NER function of both XPB and XPD is their requirement in transcription initiation as components of the basal transcription factor TFIIH, especially since XPD helicase activity is known not to be required for its role in initiation (Winkler et al. 2000) . However, there is no known similar requirement for XPG in transcription, and in fact XP-G/CS individuals are among the most severely affected of all CS patients. Fig. 2A,B) . It thus seemed likely that XPG facilitates global BER in addition to its evident requirement in TC-BER Le Page et al. 2000b) , and in fact purified XPG protein has been shown to stimulate hNTH glycosylase activity on a Tgcontaining substrate up to seven-fold in a reconstituted BER reaction (Bessho 1999; Klungland et al. 1999a ). Consistent with our cellular repair studies, this function of XPG is also distinct from its incision activity in NER, since proteins with inactivating mutations of the catalytic site (Constantinou et al. 1999 ) retain this property. The decreased rate of removal of 8-oxoG in NTS in XP-G/CS cells suggests that XPG also similarly stimulates the OGG1 glycosylase (compare lines b and c1, Fig. 2C ).
In view of the correlation between presence of clinical features of CS and the inability to carry out transcription-coupled repair of oxidative damage in every case examined to date, it seems likely that the relationship is a causal one, as is discussed further in the last section. In addition, the reduction in global BER of oxidative DNA damage in the absence of XPG in XP-G/CS cells, all of which have truncating mutations, may contribute to the additional clinical severity of XP-G/CS.
Proteins Required for TCR in Human Cells.
In addition to the previously known requirement for CSA and CSB to carry out TCR, studies of the repair of oxidative DNA damage in human cells have thus allowed the description of required 9 discrete functions in TCR of both XPG and TFIIH (through its component helicases XPB and XPD) that are separable by particular mutations from their roles in NER. At the risk of stating the obvious, there is also a requirement for active RNA polymerase II, which may not necessarily be only a passive participant in TCR once it has stalled. The mismatch repair (MMR) proteins hMSH2 and hMLH1 (Leadon and Avrutskaya 1997; Mellon and Champe 1996) and the two breast-cancer associated suppressor gene products, BRCA1 and BRCA2 (Gowen et al. 1998; Le Page et al. 2000c ) have been directly implicated in TCR by virtue of loss of strand-specific preferential repair in mutants defective in them. Of these, only hMSH2 has been implicated in both TC-NER and TC-BER, while hMLH1 is involved only in the former, and BRCA1 and BRCA2 are required only for transcription-coupled repair of oxidative lesions. The role of BRCA2 in TC-BER is more fully discussed in the article in this volume by S.A. Leadon. While neither the precise mechanism of TCR nor the roles of any of these required proteins in it (summarized in Fig. 1 ) have been elucidated, it is useful to consider what is currently known about the participants in order to devise testable models for TCR.
CSA and CSB Proteins. CSA belongs to the WD-repeat family of proteins (Henning et al. 1995) whose members have regulatory rather than catalytic roles in many cellular functions including cell division, signal transduction, mRNA modification, and transcription. These repeats structurally form a beta-propeller, first observed in the G-protein transducin β subunit (Sondek et al. 1996) . CSB contains a region of multiple ATPase/helicase motifs characteristic of the expanding and diverse SWI2/SNF2 protein family (Troelstra et al. 1992) , various members of which are implicated in chromatin remodeling during transcription. It is a DNA-dependent ATPase (Citterio et al. 1998 ) but like other members of this family does not have DNA helicase activity. However, CSB has recently been shown to modulate the conformation of double-stranded DNA and to have ATP-dependent chromatin remodeling activity, and it binds directly to core histones (Citterio et al. 2000a ). CSA and CSB antibodies microinjected into cells partially inhibit TCR after UV irradiation, with CSB antibodies having a significantly greater effect than those against CSA. The microinjected antibodies have no effect on transcription detectable by autoradiography (van Gool et al. 1997a) , although a modest effect of CSB on transcript elongation in vitro has been observed (Selby and Sancar 1997a) . From in vitro pulldown experiments, CSA was reported to associate with CSB and RNA polymerase II (Henning et al. 1995) , but in cell free extracts 10 CSB did not detectably interact with CSA (van Gool et al. 1997a ). In any case, it is clear from both in vitro and in vivo observations that CSB exists in a complex with RNA polymerase II (Selby and Sancar 1997b; Tantin et al. 1997; van Gool et al. 1997a ).
TFIIH, an Essential Basal Transcription Initiation Factor and Repair Protein.
The repair/transcription factor TFIIH is required both for promoter opening during transcription initiation by RNA polymerase II and for helix opening around lesions in NER, in addition to its separable role in TCR uncovered by studying repair of oxidative lesions. The nine subunit TFIIH complex (consisting of a six subunit core of XPB, XPD, p62, p52, p44, and p34 plus the CAK kinase subunit containing cdk7, cyclinH, and MAT1) contains two helicases, the 89 kDa XPB which has 3' to 5' activity and the 80 kDa XPD which has 5' to 3' activity. Both helicases are required in NER for formation of an open complex of approximately 25 nt asymmetrically surrounding the lesion (Evans et al. 1997a; Evans et al. 1997b ).
Only the XPB helicase is essential for promoter opening to initiate transcription, with the role of XPD in initiation evidently involving stabilization of the CAK kinase subunit of the TFIIH complex, which is XPG, a Multi-Functional Repair Protein. XPG is a 134 kDa protein having endonuclease activity specific for single-strand/double-strand junctions in DNA in which the ssDNA is 5' to the junction (O'Donovan et al. 1994 ). This activity is essential for the required role of XPG in making the first incision in NER. However, XPG is also required in a non-enzymatic capacity for occurrence of the second, 5' incision by the ERCC1/XPF heterodimer, another structure-specific endonuclease of opposite polarity, and for full opening of the helix around the lesion by TFIIH (Constantinou et al. 1999; Evans et al. 1997b; Wakasugi et al. 1997 ). There are thus now four known functions of XPG: (1) its activity as a structure-specific endonuclease in NER; (2) a non-catalytic activity in NER; (3) its activity as a cofactor for global BER of oxidative lesions, attributable at least in part to its stimulation of the hNTH glycosylase-AP lyase; and (4) its requirement in TCR. Consistent with these multiple roles, XPG has been reported to interact with a number of other proteins including TFIIH components (XPB, XPD, p62, p44), PCNA, RPA, RNA Pol II, CSB, and hNTH Bessho 1999; Gary et al. 1997; He et al. 1995; Iyer et al. 1996; Klungland et al. 1999a; Maldonado et al. 1996) . Because XPG has roles in both NER and BER throughout the genome, it may serve a role in TCR that would be analogous to that of a bacterial transcription-repair coupling factor (Selby and Sancar 1991; Selby and Sancar 1993) in recruiting the appropriate repair machinery to lesions that have blocked the progress of transcription. In any case, its stimulatory role in global BER and its required role in TC-BER place it in a central position for understanding the mechanism of TC-BER.
Sequence comparison of XPG with its smaller paralog FEN1, a flap endonuclease involved in removing RNA primers from Okazaki fragments Lieber 1997) , highlights significant regions of homology and equally significant differences (Fig. 3) . Although the two proteins have similar structure-specific endonuclease activities, both the roles that XPG plays in oxidative damage repair and its functions in NER are unique and likely to involve interactions mediated by regions of the protein not found in FEN1. This notion is supported by the nature and location of TCR-inactivating mutations in XP-G/CS and class 2 XP-G patients ( ) and unpublished results) and by a preliminary identification of TFIIH-interacting regions of XPG (Iyer et al. 1996) . A likely candidate for such interactions is the distinctive R-(for "recognition") domain of XPG that separates the active site N and I domains (Fig. 3) . It is about 600 residues long and larger than the entire FEN1, in which the corresponding region is only 18 residues. The other potential region of interest is the Cterminus of XPG, which is approximately 180 residues longer than that of FEN1. These domains are unique to XPG and are predicted to be involved in its protein-protein and protein-DNA interactions that are critical for NER, BER, and TCR.
Other These complexes initiate mismatch repair by binding to single base mismatches and loops, respectively, but have also been shown to bind to certain oxidative lesions (Duckett et al. 1996; Mu et al. 1997) .
Two-hybrid screens in yeast have detected association of MSH2 with a number of NER/TCR-related proteins: RAD2 (XPG), RAD1 (XPF), RAD10 (ERCC1), RAD14 (XPA), RAD25 (XPB), and RAD3 (XPD) (Bertrand et al. 1998) . Whether the role of the mismatch binding proteins in TCR involves their recognition and binding of the lesion, perhaps thus contributing to stalling of the RNA polymerase, is presently not known. Similarly, the function of the breast-cancer associated proteins BRCA1 and BRCA2 in TCR is not understood, but it is significant that they are required only for TCR of oxidative damage, since BRCA1 has been directly implicated in double-strand break repair (Moynahan et al. 1999 ) and both co-localize in the cell with Rad51 protein required for homologous recombination (Bhattacharyya et al. 2000; Scully et al. 1997) . BRCA2 interacts directly with Rad51 Katagiri et al. 1998) , and BRCA1 probably co-localizes by virtue of its interaction with BRCA2 ). In addition, BRCA1 associates with the hRad50-hMre11-p95 complex (Zhong et al. 1999 ) also involved in homologous recombination and responses to ionizing radiation and with the mismatch repair proteins MSH2, MSH6, and MLH (Wang et al. 2000) . Whether these interactions imply a direct relationship between TCR and repair of double-strand breaks or alternatively reflect a common signaling pathway in response to oxidative damage remains to be determined.
The potential existence of a class of novel proteins not yet associated with any human disease but essential for both transcription and TCR is suggested by the recent identification of one such protein, XAB2 (Nakatsu et al. 2000) , whose function is not yet understood. In addition, it is highly likely that TCR also involves other as-yet unidentified disease-related proteins, as indicated by the existence of a number of CS-like and UV-sensitive human syndromes in which the genetic defect remains unknown, for example UVs syndrome (Itoh et al. 1996; Ohta et al. 1999) .
Does TCR of Oxidative Lesions Proceed by BER?
Because TCR of UV damage requires all the proteins needed for NER with the exception of XPC, it is clear that NER preferentially directed to sites of blocked transcription must be the means by which the photoproducts are removed. In contrast, our studies of oxidative lesions have revealed no defect in TCR in cells in which NER is completely non-functional, thus strongly suggesting that repair of these lesions in transcribed strands proceeds by BER just as it does in NTS. However, cells from OGG1 knockout mice that are completely defective in removal of 8-oxoG from non-transcribed sequences have only a modest reduction in the rate of repair in TS (Le Page et al. 2000a ). This retention 13 of functional TCR probably explains the weak phenotype of the knockout mice themselves (Klungland et al. 1999b ). The fact that there is reduced repair of TS in the absence of OGG1 establishes that indeed BER can be targeted preferentially to transcribed strands but begs the question of the mechanism for the remaining TCR of 8-oxoG. Since there is evidently no functional complement to OGG1 for global BER of 8-oxoG, one interpretation is that strand-specific repair of 8-oxoG does not proceed primarily by the BER pathway. There are two formal possibilities: (1) existence of alternate glycosylases for 8-oxoG that function primarily in TCR, are optimized for interaction with the TCR machinery, and hence are not detectable in vitro; or (2) repair pathways other than BER function in TCR of oxidative lesions.
With respect to the first possibility, there is at least one potential candidate for an alternate 8-oxoG glycosylase that may have specialized applications (Hazra et al. 1998) , and the existence of two glycosylases for removal of 8-oxoG in E. coli lends support to the idea that mammalian cells could be expected to have more than one. The second possibility is not ruled out but seems unlikely for a number of reasons. If the putative alternative repair mechanism is NER, it must be completely redundant to BER, since no effect of its absence is detectable in cells that are competent for BER, whether the NER defect is due to mutations in XPA, XPD (without CS complications), XPF, or XPG (class 1). Given the requirement for MSH2 for TCR, mismatch repair could conceivably be directly involved in lesion removal. However, since TCR of oxidative lesions is not affected by defects in MLH1 that eliminate mismatch repair (Leadon and Avrutskaya 1997) , this is unlikely to be the mechanism. Similarly, given the requirement for BRCA1 and BRCA2, a direct role for homologous recombination in TCR of oxidative damage could be proposed. This is even less plausible, however, for two reasons: (1) the assay for repair of Tg in the genome directly detects loss of the damaged base itself, and if the lesion were exchanged by recombination to allow transcription to proceed, it would still be present in the genome rather than removed; and (2) the assay for 8-oxoG involves use of a shuttle vector containing a single damaged base at a defined location, so that there is no undamaged homolog available for recombination.
Definitive assignment of BER as the operative repair mechanism in TCR of oxidative damage will require either an assay that detects release of damaged bases during TCR in the cell or construction of a cell line with known BER defects that result in loss of TCR. Meanwhile, it is a good working 14 assumption that preferential repair of oxidative lesions in transcribed strands does occur by TC-BER, especially since XPG, which is absolutely required for TCR of oxidative lesions, also has a clear role in global BER, and application of "Occam's razor" suggests that its involvement in both processes should involve related mechanisms. It is likely that TCR of oxidative lesions in the cell involves preferential recruitment of the global BER pathway to transcription-blocking lesions by the TCR machinery.
Mechanism of TCR: Many Remaining Questions and Some Answers
Although the process of transcription-coupled repair was identified some fifteen years ago, its mechanism is still largely unknown, and it is even likely that some of the players still remain to be identified. Progress in elucidating the mechanistic details of TCR has been hampered by the lack of an efficient in vitro system to study it, but current efforts in a number of laboratories to identify and characterize the relevant protein-protein interactions and the multi-protein complexes likely to be involved, coupled with new methods for visualizing events in living cells, hold considerable promise.
These efforts will be aided by consideration of the conceptual framework resulting from the cellular studies of TCR that help to define the outlines of the mechanism.
Requirement for release of the stalled RNA polymerase. A striking feature of the loss of TCR for oxidative lesions in XP/CS or CS cells in the case of a single 8-oxoG in a shuttle vector is that not only is the lesion not preferentially repaired when it is in a transcribed sequence, but no removal at all is observed over the course of the experiment, even when the plasmid is resident in the host human cell for three days (shown in Fig. 2C , line c2 for early times; Le Page et al. 2000b ). This is so despite the fact that the cells are obviously proficient for the relevant repair process per se, as evidenced by complete Page et al. 2000b ). The simplest interpretation of these observations is that RNA polymerase is stalled at the lesion and that it remains there in cells defective in TCR, preventing access to the lesion even by global repair processes. Why the impediment to repair imposed by the stalled RNAP has not been detectable in most experiments in which damage is introduced into the genome itself (e.g., compare line b in Fig. 2A ,B to line c2 in 2C), is not entirely clear but presumably has to do with lack of sufficient resolution of affected lesions due to the relatively high levels of damage and the stochastic nature of its introduction. Importantly, however, the same conclusion can be drawn from measurements of repair of UV-induced lesions at nucleotide resolution in active chromosomal genes in yeast, in which an impediment to NER caused by blocked transcription was detected in the absence of Rad26, the yeast homolog of CSB (Tijsterman and Brouwer 1999) .
These results have thus provided strong experimental support for the model that TCR has two functions: (1) recruitment of appropriate repair proteins to lesions that are blocking transcription, thus allowing them to be repaired more rapidly than lesions elsewhere in the genome, and (2) perhaps more importantly, removal of the stalled RNAP to allow repair to occur. A number of different scenarios can be envisioned for how the RNAP might be removed, including release and degradation of the stalled RNAP (Bregman et al. 1996; Ratner et al. 1998 A current model to explain the loss of TCR in CS cells invokes reduced transcription initiation after damage and hence less opportunity for transcription arrest at downstream lesions (Rockx et al. 2000; van Oosterwijk et al. 1996) . The reduced initiation is attributed to a postulated direct, non-repairassociated role of the CS proteins in regeneration of the hypo-phosphorylated, initiation-competent form of RNA polymerase from the elongation-associated form. Aside from the fact that this hypothesis might predict significantly decreased transcription initiation in undamaged CS cells, which is not observed, the 8-oxoG results in the shuttle vector system indicate to the contrary that the defect in TCR is directly (6) Transcription must resume, either by re-elongation of a displaced polymerase or by re-initiation from the promoter. These steps will be considered in order.
A clear requirement of the model is that lesions repaired by TCR must be lesions that block elongation by RNA polymerase II. While this requirement has been shown to be satisfied in vitro for cyclobutane pyrimidine dimers induced by UV for both prokaryotic and mammalian RNA polymerases, the situation is much less clear for oxidative lesions, and indeed many of them including 8-oxoG would not be expected to block transcription since they are readily copied by DNA polymerases (reviewed in . One possibility is that such lesions are converted into transcription blocks by binding of a protein, with mismatch binding proteins being a rather obvious possibility. Such a role could explain the requirement for MSH2 in TCR, particularly TC-BER. Interestingly, mouse ES cells deficient in MSH2 had increased survival after exposure to ionizing radiation due to a failure to induce apoptosis (DeWeese et al. 1998) . Since blockage of RNAP II is a potent signal for apoptosis, (Ljungman and Zhang 1996) , this result would be consistent with failure to block transcription in the MSH2-deficient cells.
A number of lines of evidence suggest that CSB is involved in recognition of the stalled
polymerase. An attractive model is that the known interaction of CSB with RNAP II targets it to sites of blocked transcription. Such a model is strongly supported by in vitro studies that further suggest that CSB can recruit TFIIH to the ternary complex with DNA and RNA (Tantin 1998; Tantin et al. 1997 ).
Whether XPG is recruited along with TFIIH by virtue of their direct interaction or whether it too may participate early in the recognition step is not known. What is clear, however, is that at a minimum CSB, XPG and TFIIH are all required for release of the stalled RNA polymerase, since the lesion does not become accessible for repair in the absence of any of these (Le Page et al. 2000b ). Examination of TCR at nucleotide resolution in both yeast and human cells has revealed that CSB is not required for repair of transcribed DNA near the transcription initiation site, prior to the point at which TFIIH dissociates from the elongating RNAP II. This result suggests that CSB (and CSA in the human cells) is dispensable in TCR if TFIIH is already present at the polymerase when it stalls (Tijsterman et al. 1997; Tu et al. 1997) . It further implies that the stalled RNA polymerase is released by TFIIH, perhaps together with XPG, although the involvement of other as yet unknown proteins is not ruled out.
Release of the RNA polymerase exposes the lesion for repair, but since either a bulky lesion handled by NER or an oxidative lesion handled by BER may have been the initiating event, there must be some mechanism for lesion verification and determination of which repair machinery to recruit.
Since the hallmark of TCR is that repair in TS is faster than repair elsewhere in the genome, this recruitment must be more efficient than in the global process, and/or the repair activities must be stimulated in the context of TCR. For lesions repaired by the NER pathway, recruitment may be relatively straightforward since TFIIH and XPG, which along with XPA and RPA are thought to perform lesion verification following damage recognition by XPC-HR23B in global NER (Sugasawa et al. 1998) , are already present. Thus only XPA and RPA would need to be recruited in addition. For lesions repaired by the BER pathway (Fig. 4, right) , it is likely that XPG is involved in recruitment of the glycosylase, since NTH catalytic activity and DNA binding are strongly stimulated by XPG in vitro (Bessho 1999; Klungland et al. 1999a) , and the decreased global BER of 8-oxoG in XP-G/CS cells suggests that XPG also stimulates OGG1 (Le Page et al. 2000a) . Notably, APE1 is also a favorable candidate for recruitment to the lesion and stimulation by the TCR machinery, in particular XPG, since the 3′-diesterase activity of APE1 that is required for removal of the 3′-moieties left by AP lyase action or ionizing radiation-induced 3′-blocked ends is relatively weak and may be the rate-limiting step in BER of oxidative damage Mitra et al. 1997; Ramana et al. 1998) . A potential role for XPG in stimulation of the glycosylase/AP lyase and the 3′-diesterase steps in global BER as well as in TC-BER of oxidative damage is depicted schematically in Fig. 5 .
The Molecular Basis for Cockayne Syndrome
A considerable challenge to defining relationships between molecular defect and patient phenotype is that different mutations affecting either the XPG structure-specific endonuclease or the The transcription hypothesis is based on the requirement for TFIIH in transcription initiation (Tirode et al. 1999) and is supported by the finding that purified TFIIH containing mutant XPB or XPD proteins similar to those found in XP/CS patients is less competent to initiate transcription in vitro Hwang et al. 1996) . According to this hypothesis, the repair defect in CS cells is secondary to a transcription deficiency, and the lack of TCR is attributed to relatively low levels of transcription.
However, any effect of CS-B defects on transcription in the cell would have to be very subtle, since there is no discernible effect of injecting neutralizing antibodies into normal cells and since knockout mice are viable (van der Horst et al. 1997; van Gool et al. 1997a) . Furthermore, there is no known role for XPG in transcription, and indeed upstream transcription of the TAg gene on a shuttle vector was quite active in XP-G/CS cells, indicating that there is no overall deficit in transcription in these cells (Le Page et al. 2000b) . Perhaps the most serious problem with the transcription hypothesis, however, is that CS is primarily a postnatal syndrome. Thus, although CS babies are relatively small at birth, the major developmental failure appears in infancy, childhood, or occasionally even later in less severe cases.
This time course of the clinical symptoms is not consistent with the primary defect being in basal
transcription.
An alternative theory that better fits with these facts is based on the demonstrated correlation of clinical CS with inability to carry out TCR of oxidative damage. The TCR defect is manifested by failure to release RNA polymerase stalled at endogenous lesions with a secondary inability to repair the lesions even by global BER, thus resulting over time in cumulative loss of RNA polymerase available for transcription initiation. One consequence would be eventual transcription insufficiency, but in addition the blocked transcription would provide a powerful signal for apoptosis, resulting in destruction of those cell types in which apoptosis occurs. Since the oxygen tension is presumably much higher after birth than in utero, the relatively normal prenatal development with profound and progressive postnatal developmental failure (as unrepairable oxidative lesions and stalled polymerases accumulate, and unscheduled apoptosis is initiated) is consistent with this explanation. The most metabolically active tissues and those most susceptible to apoptosis would thus be expected to be the most affected in CS patients, and this prediction does fit the clinical picture (Nance and Berry 1992) . TCR machinery may also be involved in maintaining efficient transcription elongation on non-damaged DNA by the same mechanism employed for remedying stalling of RNA polymerase at lesions, whether derived from endogenous or environmental sources. Examples of situations in which this might occur are strong natural pause sites or regions of strong secondary structure in the nascent transcript (Yu et al. 2000) . In this repair-based model developed here and elsewhere (van Gool et al. 1997b) , the primary molecular defect in Cockayne syndrome is an inability to repair endogenous oxidative lesions that stall RNA polymerase, but this repair defect is ultimately manifest as a defect in transcription.
Conclusion
The process of transcription-coupled repair is being revealed as an intricately choreographed and dynamic network involving an unexpectedly large number of ensembles and being more intimately connected to the life of the cell than could have been envisioned when the process was discovered in the 20 laboratory of Dr. Philip Hanawalt at Stanford some 15 years ago. It now seems that the TCR machinery can direct either NER or BER to lesions that are particularly threatening because they are blocking progress of RNA polymerase, and in doing so it also calls mismatch repair and possibly homologous recombination proteins into play. Further insights into the mechanism by which this fascinating and essential process allows us to survive the perils of an oxygen world will almost certainly depend on approaches that allow understanding of the organization and dynamics of large multi-protein complexes.
Figure Legends eliminate (D77A and E791A) or greatly reduce (A792V) the endonuclease activity of XPG (Constantinou et al. 1999 ). The latter is a naturally occurring mutation in the class 1 XP-G patient XP125LO. Also shown are mutations found in three XP-G/CS patients, all of which would result in a truncated protein ). Global BER is the major pathway for repair of base lesions, and has been shown in vitro to result in insertion of either short (1 nt) or long (2-10 nt) patches, as described in the text. TCR of lesions is initiated with the stalling of RNA pol II at a lesion and requires at a minimum TFIIH, CSB, XPG, MutS, and BRCA1 and BRCA2 (not shown). The stalled RNA polymerase must be released from the lesion in order to make the lesion accessible to repair. BER enzymes are likely recruited to repair the lesion, allowing the resumption of transcription. Whether the original transcript can be re-elongated or whether transcription must be re-initiated from the promoter has not been established. 
